Drug major Glenmark Pharma said it has received final approval from
the US health regulator for Dimethyl Fumarate delayed-release
capsules, used for the treatment of relapsing forms of multiple
sclerosis in adults.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/glenmark-pharma-gets-usfda-nod-to-market-drug-for-relapsing-multiple-sclerosis/articleshow/78527839.cms
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment